Director, DMPK
Moderna Therapeutics
Dr. Doug Burdette is Head of DMPK and Clinical Pharmacology at Moderna Therapeutics. He received his academic training at the University of Michigan (BS), Michigan State University (MS, PhD), and U. C. Berkeley (postdoctoral research). His 25+ year career in the pharmaceutical/biopharma industry spans early target discovery through post-approval support (global) across a wide range of therapeutic areas and drug modalities. He has actively participated in and consulted for academic/industry/regulatory consortia and professional societies throughout his career. His peer reviewed publications and presentations include topics related to assay development; high throughput screening; enzymology; protein biochemistry; drug discovery, ADME and safety; and DDI.
Disclosure information not submitted.
Monday, October 17, 2022
8:30 AM – 9:00 AM ET
Monday, October 17, 2022
9:00 AM – 10:30 AM ET